{
  "id": 475,
  "name": "candesartan cilexetil",
  "cas_reg_no": "145040-37-5",
  "smiles": "CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1",
  "inchikey": "GHOSNRCGJFBJIB-UHFFFAOYSA-N",
  "inchi": "InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)",
  "formula": "C33H34N6O6",
  "molweight": 610.671,
  "xrefs": [
    {
      "xref_type": "VUID",
      "xref": "4021148"
    },
    {
      "xref_type": "NUI",
      "xref": "N0000179517"
    },
    {
      "xref_type": "KEGG_DRUG",
      "xref": "D00522"
    },
    {
      "xref_type": "SECONDARY_CAS_RN",
      "xref": "139481-59-7"
    },
    {
      "xref_type": "VANDF",
      "xref": "4021148"
    },
    {
      "xref_type": "VANDF",
      "xref": "4021151"
    },
    {
      "xref_type": "UMLSCUI",
      "xref": "C0527379"
    },
    {
      "xref_type": "UMLSCUI",
      "xref": "C0717550"
    },
    {
      "xref_type": "CHEBI",
      "xref": "CHEBI:3348"
    },
    {
      "xref_type": "CHEBI",
      "xref": "CHEBI:149509"
    },
    {
      "xref_type": "ChEMBL_ID",
      "xref": "CHEMBL1014"
    },
    {
      "xref_type": "DRUGBANK_ID",
      "xref": "DB00796"
    },
    {
      "xref_type": "MESH_SUPPLEMENTAL_RECORD_UI",
      "xref": "C077793"
    },
    {
      "xref_type": "PUBCHEM_CID",
      "xref": "2540"
    },
    {
      "xref_type": "IUPHAR_LIGAND_ID",
      "xref": "8352"
    },
    {
      "xref_type": "MESH_SUPPLEMENTAL_RECORD_UI",
      "xref": "C081643"
    },
    {
      "xref_type": "INN_ID",
      "xref": "7239"
    },
    {
      "xref_type": "UNII",
      "xref": "S8Q36MD2XX"
    },
    {
      "xref_type": "PUBCHEM_CID",
      "xref": "2541"
    },
    {
      "xref_type": "IUPHAR_LIGAND_ID",
      "xref": "587"
    },
    {
      "xref_type": "DRUGBANK_ID",
      "xref": "DB13919"
    },
    {
      "xref_type": "RXNORM",
      "xref": "135481"
    },
    {
      "xref_type": "MMSL",
      "xref": "188909"
    },
    {
      "xref_type": "MMSL",
      "xref": "7490"
    },
    {
      "xref_type": "MMSL",
      "xref": "d04322"
    },
    {
      "xref_type": "NDDF",
      "xref": "007275"
    },
    {
      "xref_type": "NDDF",
      "xref": "007276"
    },
    {
      "xref_type": "SNOMEDCT_US",
      "xref": "108587008"
    },
    {
      "xref_type": "SNOMEDCT_US",
      "xref": "372512008"
    },
    {
      "xref_type": "SNOMEDCT_US",
      "xref": "386878000"
    }
  ],
  "synonyms": [
    "TCV 116",
    "TCV-116",
    "candesartan cilexetil"
  ],
  "atcs": [
    {
      "atc_code": "S02CA04",
      "atc_l1_code": "S",
      "atc_l1_name": "SENSORY ORGANS",
      "atc_l2_code": "S02",
      "atc_l2_name": "OTOLOGICALS",
      "atc_l3_code": "S02C",
      "atc_l3_name": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
      "atc_l4_code": "S02CA",
      "atc_l4_name": "Corticosteroids and antiinfectives in combination",
      "atc_substance": "triamcinolone and antiinfectives"
    },
    {
      "atc_code": "S02CA05",
      "atc_l1_code": "S",
      "atc_l1_name": "SENSORY ORGANS",
      "atc_l2_code": "S02",
      "atc_l2_name": "OTOLOGICALS",
      "atc_l3_code": "S02C",
      "atc_l3_name": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
      "atc_l4_code": "S02CA",
      "atc_l4_name": "Corticosteroids and antiinfectives in combination",
      "atc_substance": "fluocinolone acetonide and antiinfectives"
    },
    {
      "atc_code": "S02CA06",
      "atc_l1_code": "S",
      "atc_l1_name": "SENSORY ORGANS",
      "atc_l2_code": "S02",
      "atc_l2_name": "OTOLOGICALS",
      "atc_l3_code": "S02C",
      "atc_l3_name": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
      "atc_l4_code": "S02CA",
      "atc_l4_name": "Corticosteroids and antiinfectives in combination",
      "atc_substance": "dexamethasone and antiinfectives"
    },
    {
      "atc_code": "S02CA07",
      "atc_l1_code": "S",
      "atc_l1_name": "SENSORY ORGANS",
      "atc_l2_code": "S02",
      "atc_l2_name": "OTOLOGICALS",
      "atc_l3_code": "S02C",
      "atc_l3_name": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
      "atc_l4_code": "S02CA",
      "atc_l4_name": "Corticosteroids and antiinfectives in combination",
      "atc_substance": "fludrocortisone and antiinfectives"
    }
  ],
  "targets": [
    {
      "target_id": 95,
      "target_name": "Cytochrome P450 3A4",
      "gene": "CYP3A4",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 99,
      "target_name": "Sodium-dependent noradrenaline transporter",
      "gene": "SLC6A2",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "Ki",
      "act_comment": "DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 107,
      "target_name": "Alpha-2B adrenergic receptor",
      "gene": "ADRA2B",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "Ki",
      "act_comment": "DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 129,
      "target_name": "Beta-3 adrenergic receptor",
      "gene": "ADRB3",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "Ki",
      "act_comment": "DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 148,
      "target_name": "Adenosine receptor A3",
      "gene": "ADORA3",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "Ki",
      "act_comment": "DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 268,
      "target_name": "Cytochrome P450 2C9",
      "gene": "CYP2C9",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 385,
      "target_name": "Type-1 angiotensin II receptor",
      "gene": "AGTR1",
      "action_type": "ANTAGONIST",
      "act_source": "UNKNOWN",
      "act_type": null,
      "act_comment": null,
      "relation": null,
      "moa": 1.0,
      "moa_source": "CHEMBL",
      "moa_source_url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014",
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 387,
      "target_name": "Epidermal growth factor receptor",
      "gene": "EGFR",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 546,
      "target_name": "Receptor tyrosine-protein kinase erbB-2",
      "gene": "ERBB2",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 621,
      "target_name": "Thromboxane-A synthase",
      "gene": "TBXAS1",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 1815,
      "target_name": "Type-1 angiotensin II receptor",
      "gene": "AGTR1",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": null,
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 2293,
      "target_name": "Cruzipain",
      "gene": null,
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "IC50",
      "act_comment": "Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100",
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    },
    {
      "target_id": 2419,
      "target_name": "Type-1 angiotensin II receptor",
      "gene": "AGTR1",
      "action_type": null,
      "act_source": "CHEMBL",
      "act_type": "Ki",
      "act_comment": null,
      "relation": "=",
      "moa": NaN,
      "moa_source": null,
      "moa_source_url": null,
      "ref_pmid": null,
      "ref_doi": null,
      "ref_title": null,
      "ref_year": null
    }
  ],
  "indications": [
    {
      "omop_concept_id": 21001432,
      "omop_concept_name": "Hypertensive disorder",
      "umls_cui": "C0020538",
      "umls_semantic_type": "T047",
      "snomed_conceptid": 38341003,
      "snomed_full_name": "Hypertensive disorder"
    },
    {
      "omop_concept_id": 21001578,
      "omop_concept_name": "Chronic heart failure",
      "umls_cui": "C0264716",
      "umls_semantic_type": "T047",
      "snomed_conceptid": 48447003,
      "snomed_full_name": "Chronic heart failure"
    }
  ]
}